Post-earnings recap
Reported
Thu, Nov 7, 2024
EPS actual
$0.03
EPS est.
$-1.89
EPS surprise
+101.58%
1-day move
-2.95%
Moderna's earnings report shows a significant positive surprise in EPS, indicating better-than-expected performance in that area. However, the stock reacted negatively, dropping nearly 3% in a single day. This decline may reflect investor concerns about the lack of revenue details and future guidance, which are critical for assessing the company's growth trajectory.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.03 | N/A | +101.58% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed a cautious optimism about future projects. They emphasized their commitment to advancing their pipeline despite current revenue challenges.
Management highlighted ongoing efforts in vaccine development.
They acknowledged challenges in revenue generation but remain focused on innovation.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—